Literature DB >> 34613879

Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.

Bondi Arifin1,2, Titik Anas1,3.   

Abstract

The development of safe and effective COVID-19 vaccines as well as their delivery to people's arms are the best hope for ending the COVID-19 pandemic. However, the implementation of vaccination varies greatly across countries, with the developing countries lagging behind. This study investigates Indonesia's vaccination experiences, challenges, and acceleration over the course of implementation period. This study provides simulations to estimate the vaccination rate using time-series forecasting machine learning. We use Administrative data and Survey results in our analysis. Our findings suggest limited vaccine availability had caused low-coverage vaccination implementation in the early stage of vaccination implementation period. However, following the increased availability of vaccine, the vaccination rate accelerates up to 600% times. The government of Indonesia utilized strategic public places, public and private offices, and engaging private sectors in the phase two implementation to accelerate the vaccination implementation. Indonesia might reach 63.1 million individuals vaccinated at the end of March 2022, or 35% of the targeted population with up to April 2021 vaccination rate. To accelerate, government introduced a number of new strategies including door-to-door persuasion through neighborhood association (RT), educating individuals, and providing transportation from their home to the vaccination facility. We expect new strategies could further improve vaccination speed by around 1.4 million to 3.5 million individuals per day.

Entities:  

Keywords:  COVID-19; vaccination acceleration; vaccines

Mesh:

Substances:

Year:  2021        PMID: 34613879      PMCID: PMC8828161          DOI: 10.1080/21645515.2021.1975450

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   4.526


  21 in total

Review 1.  HPV vaccination: the promise & problems.

Authors:  R Sankaranarayanan
Journal:  Indian J Med Res       Date:  2009-09       Impact factor: 2.375

Review 2.  Development and deployment of COVID-19 vaccines for those most vulnerable.

Authors:  Wayne C Koff; Theodore Schenkelberg; Tere Williams; Ralph S Baric; Adrian McDermott; Cheryl M Cameron; Mark J Cameron; Matthew B Friemann; Gabriele Neumann; Yoshihiro Kawaoka; Alyson A Kelvin; Ted M Ross; Stacey Schultz-Cherry; Timothy D Mastro; Frances H Priddy; Kristine A Moore; Julia T Ostrowsky; Michael T Osterholm; Jaap Goudsmit
Journal:  Sci Transl Med       Date:  2021-02-03       Impact factor: 17.956

3.  Vaccine production, distribution, access, and uptake.

Authors:  Jon Smith; Marc Lipsitch; Jeffrey W Almond
Journal:  Lancet       Date:  2011-06-12       Impact factor: 79.321

Review 4.  Chapter 25: Education, training, and communication for HPV vaccines.

Authors:  Jacqueline Sherris; Allison Friedman; Scott Wittet; Philip Davies; Marc Steben; Mona Saraiya
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

5.  The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland.

Authors:  S W Michelsen; B Soborg; A Koch; L Carstensen; S T Hoff; E M Agger; T Lillebaek; H C F Sorensen; J Wohlfahrt; M Melbye
Journal:  Thorax       Date:  2014-06-26       Impact factor: 9.139

6.  The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.

Authors:  Thomas R Wojda; Pamela L Valenza; Kristine Cornejo; Thomas McGinley; Sagar C Galwankar; Dhanashree Kelkar; Richard P Sharpe; Thomas J Papadimos; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2015 Oct-Dec

7.  AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal.

Authors:  Ranjit Sah; Sunil Shrestha; Rachana Mehta; Sohan Kumar Sah; Ali A Rabaan; Kuldeep Dhama; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2021-02-10       Impact factor: 6.211

8.  The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.

Authors:  Seyed M Moghadas; Thomas N Vilches; Kevin Zhang; Chad R Wells; Affan Shoukat; Burton H Singer; Lauren Ancel Meyers; Kathleen M Neuzil; Joanne M Langley; Meagan C Fitzpatrick; Alison P Galvani
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

Review 9.  Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Authors:  Olivier J Wouters; Kenneth C Shadlen; Maximilian Salcher-Konrad; Andrew J Pollard; Heidi J Larson; Yot Teerawattananon; Mark Jit
Journal:  Lancet       Date:  2021-02-12       Impact factor: 79.321

10.  Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia.

Authors:  Harapan Harapan; Abram L Wagner; Amanda Yufika; Wira Winardi; Samsul Anwar; Alex Kurniawan Gan; Abdul Malik Setiawan; Yogambigai Rajamoorthy; Hizir Sofyan; Mudatsir Mudatsir
Journal:  Front Public Health       Date:  2020-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.